White Paper
min read

ValGenesis_21 CFR Part 11 Compliance Assessment

September 19, 2024

Comments

Leave a reply. Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

ValGenesis_21 CFR Part 11 Compliance Assessment

Reviewing ValGenesis' compliance with the regulations outlined in 21 CFR Part 11, focusing on electronic records and digital signature standards in the pharmaceutical industry.

Reviewing ValGenesis' compliance with the regulations outlined in 21 CFR Part 11, focusing on electronic records and digital signature standards in the pharmaceutical industry.

Start Date
End Date
Event Location